2026 Catalyst Calendar | BioMed Nexus
Limited Time: Lock in 2026 pricing.

2026 Catalyst Calendar: Track Every Market-Moving Event

The most comprehensive biotech catalyst calendar. Track FDA PDUFA decisions, Phase 3 readouts, patent expirations, and earnings calls—all in one place.

70+ Catalysts
$100B Cap at Risk
Weekly Updates

The Problem

Every week, billions of dollars shift in biotech based on a handful of pivotal moments. Miss one, and you're reacting to price moves you didn't see coming.

But tracking these catalysts is a full-time job. PDUFA dates are buried in SEC filings. Phase 3 timelines shift quarterly. You end up checking ten different sites and still missing critical events.

The Solution

We built the calendar we couldn't find. Every PDUFA decision, Phase 3 readout, patent expiration, and earnings call that matters in 2026—tracked in one place.

Q1 2026 Events (Preview)

January 12-15, 2026
JPM Healthcare Conference
San Francisco, CA | 8,000+ attendees | The tone-setter for M&A and pipeline updates.
High Impact
January 14, 2026
Fortress Biotech (FBIO) PDUFA
CUTX-101 for Menkes disease. Priority Review Voucher eligible (~$100M value).
High Impact
April 8, 2026
Bristol-Myers Squibb PDUFA
Opdivo + AVD for Stage III/IV Hodgkin lymphoma.
May 29, 2026
ASCO Annual Meeting
Chicago | 40,000+ oncology professionals.
November 21, 2026
Eliquis Patent Expiration
Major LOE event for Pfizer/BMS ($10B+ revenue).
🔒

Unlock 66+ More Events

Get the full 2026 schedule: PDUFAs, Phase 3s, and Patent Expirations.

Unlock Full Calendar

What You Get

Complete Coverage

70+ FDA PDUFA dates, Phase 3 readouts, patent expirations, earnings, and conferences.

Weekly Updates

Every Monday: date changes, new FDA filings, and "This Week's Catalysts" email briefing.

Daily Intelligence

Includes full BioMed Nexus newsletter access: daily analysis delivered at 6am EST.

Pricing

Plan
Regular Price
Your Price
Pro Access (Yearly)
Individual License
$395/yr
Team Access
Up to 5 team members
$1,975
$1,500/yr
BUNDLE SAVE
Upgrade to Premium
🔒 SSL Secure Payment ✅ 30-Day Money-Back Guarantee

Stay Ahead of the Market

Get the calendar used by 95,000+ professionals.

Get Instant Access
© 2026 BioMed Nexus. All rights reserved.

Biotech News

Breakthroughs, pipelines, data drops, and deals shaping the biotech landscape.

MedTech News

Device innovation, diagnostics, tools, and platforms redefining patient care.

2026 Catalyst Calendar

FDA Grants Clearance to Nyxoah’s Genio Sleep Apnea Device

The FDA has granted clearance to Nyxoah’s innovative Genio system, a breakthrough hypoglossal nerve stimulation device designed to treat obstructive sleep apnea. This regulatory approval marks a significant milestone in sleep medicine, offering patients a new minimally invasive treatment option that could transform care for

Read More »

Pharma News

Regulatory moves, commercial strategy, and major therapeutic developments.

About BioMed Nexus

BioMed Nexus delivers a fast, daily industry briefing for leaders across biotech, medtech, and pharma. Every weekday morning, we curate the most important developments, high-signal insights, and need-to-know updates so you can stay informed, move quickly, and make confident decisions in a rapidly evolving landscape.

Join 85,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters